Trang kết quả 13 cho Khu vực: Chăm sóc sức khỏe Ngành: Công nghệ sinh học Thị trường chứng khoán - Báo giá & giá
Danh sách tất cả các chứng khoán và vốn chủ sở hữu kèm giá, vốn hoá thị trường, PE và EPS
Tất cả các quốc gia
- {{country.name}}
- Tất cả các quốc gia
- Hoa Kỳ (1011)
- Úc (58)
- Áo (16)
- Bỉ (7)
- Brazil (16)
- Canada (83)
- Trung Quốc (94)
- Đan Mạch (6)
- Phần Lan (4)
- Pháp (41)
- Đức (737)
- Hồng Kông (46)
- Ấn Độ (19)
- Ai-len (1)
- Israel (19)
- Ý (4)
- Nhật Bản (37)
- Mexico (28)
- Hà Lan (3)
- New Zealand (1)
- Na Uy (14)
- Ba Lan (9)
- Nga (2)
- Hàn Quốc (10)
- Tây Ban Nha (4)
- Thụy Điển (70)
- Thụy Sĩ (11)
- Đài Loan (67)
- Thái Lan (2)
- Thổ Nhĩ Kỳ (1)
- Vương quốc Anh (69)
Tất cả các sàn giao dịch
- {{item.name}}
- Tất cả các sàn giao dịch
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (278)
- NasdaqGM (142)
- NasdaqGS (239)
- NSE (10)
- NYSE (10)
- NYSE American (20)
- NZSE (1)
- Oslo (14)
- Other OTC (322)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (38)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
Chăm sóc sức khỏe (2608)
- {{item.name}}
- Tất cả các khối
- Chăm sóc sức khỏe (2608)
Công nghệ sinh học (2608)
- {{item.name}}
- Tất cả các ngành
- Công nghệ sinh học (2608)
- Nhà sản xuất thuốc - Chung (279)
- Nhà sản xuất thuốc - Biệt dược & Thuốc gốc (1702)
- Gói y tế (57)
- Cơ sơ chăm sóc y tế (554)
- Nhà bán lẻ thuốc (155)
- Dịch vụ thông tin sức khỏe (420)
- Thiết bị y tế (913)
- Thiết bị & nguồn cung y tế (502)
- Chẩn đoán & nghiên cứu (427)
- Phân phối y tế (138)
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS |
|---|
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Exelixis, Inc. EX9.F | $19.2 20.99 USD |
-0.08
|
$5.64B 6.16B USD | $505 552.03 USD | $19.2 20.99 USD | $19.2 20.99 USD | $5.64B 6.16B USD | 32.00 | $0.6 0.66 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $41.25 45.09 USD |
+0.71
|
$5.34B 5.83B USD | $5 5.47 USD | $41.25 45.09 USD | $41.25 45.09 USD | $5.34B 5.83B USD | 18.58 | $2.22 2.43 USD | |
| Ionis Pharmaceuticals, Inc. ISI.F | $35.47 38.77 USD |
+3.93
|
$5.18B 5.66B USD | $1.2K 1.31K USD | $35.47 38.77 USD | $35.47 38.77 USD | $5.18B 5.66B USD | 0 | -$2.46 -2.6 USD | |
| Zealand Pharma A/S ZLDPF | $90.7 — |
+2.28
|
$5.65B — | $476 — | $90.7 — | $91 — | $5.65B — | 0 | -$1.8 — | |
| BridgeBio Pharma, Inc. 2CL.F | $27.1 29.62 USD |
-0.18
|
$5.07B 5.54B USD | $300 327.94 USD | $26.93 29.44 USD | $27.1 29.62 USD | $5.07B 5.54B USD | 0 | -$2.97 -3.2 USD | |
| Abcam ABCM | $23.99 — |
0
|
$5.52B — | $0 — | $0 — | $0 — | $5.52B — | 0 | $0 — | |
| Akeso, Inc. 4RY.F | $5.35 5.85 USD |
-6.96
|
$4.83B 5.27B USD | $351 383.69 USD | $5.35 5.85 USD | $5.55 6.07 USD | $4.83B 5.27B USD | 17.25 | $0.31 0.34 USD | |
| Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
| Madrigal Pharmaceuticals, Inc. YDO1.F | $220.9 241.47 USD |
+4.69
|
$4.76B 5.2B USD | $10 10.93 USD | $210.6 230.21 USD | $220.9 241.47 USD | $4.76B 5.2B USD | 0 | -$21.32 -23.3 USD | |
| Apellis Pharmaceuticals, Inc. 1JK.F | $39.04 42.68 USD |
+4.72
|
$4.76B 5.2B USD | $20 21.86 USD | $39.03 42.67 USD | $39.04 42.68 USD | $4.76B 5.2B USD | 0 | -$3.16 -3.4 USD | |
| Halozyme Therapeutics, Inc. HALO.MX | $680 40.26 USD |
0
|
$86.55B 5.12B USD | $0 0 USD | $680 40.26 USD | $680 40.26 USD | $86.55B 5.12B USD | 21.27 | $31.96 1.89 USD | |
| Abcam ABCZF | $22.25 — |
+0.68
|
$5.12B — | $4K — | $22.25 — | $22.25 — | $5.12B — | 2225.00 | $0.01 — | |
| SK Biopharmaceuticals Co., Ltd. 326030.KS | $86,400 65.22 USD |
-2.15
|
$6.77T 5.11B USD | $52.15K 39.37 USD | $86,300 65.14 USD | $88,100 66.5 USD | $6.77T 5.11B USD | 0 | $0 0 USD | |
| ALK-Abelló A/S 4AJ0.F | $20.1 21.97 USD |
0
|
$4.59B 5.02B USD | $2.16K 2.36K USD | $20.1 21.97 USD | $20.1 21.97 USD | $4.59B 5.02B USD | 57.42 | $0.35 0.38 USD | |
| Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $88 96.2 USD |
+1.97
|
$4.58B 5.01B USD | $30 32.79 USD | $87.55 95.7 USD | $88 96.2 USD | $4.58B 5.01B USD | 33.97 | $2.59 2.83 USD | |
| Krystal Biotech, Inc. 4KB.SG | $149.7 163.64 USD |
-0.13
|
$4.39B 4.8B USD | $0 0 USD | $149.7 163.64 USD | $150.6 164.63 USD | $4.39B 4.8B USD | 74.47 | $2.01 2.2 USD | |
| Krystal Biotech, Inc. 4KB.F | $150.25 164.24 USD |
+0.23
|
$4.39B 4.8B USD | $7 7.65 USD | $150.2 164.19 USD | $150.25 164.24 USD | $4.39B 4.8B USD | 74.75 | $2.01 2.2 USD | |
| Financière de Tubize SA FTD.F | $96.6 105.6 USD |
+0.52
|
$4.37B 4.78B USD | $4 4.37 USD | $96.6 105.6 USD | $96.6 105.6 USD | $4.37B 4.78B USD | 48.78 | $1.98 2.16 USD | |
| ImmunityBio, Inc. 26CA.F | $6.2 6.78 USD |
-1.8
|
$4.33B 4.74B USD | $1.32K 1.44K USD | $5.97 6.52 USD | $6.29 6.88 USD | $4.33B 4.74B USD | 0 | -$0.99 -1.08 USD | |
| Financière de Tubize SA FTD.SG | $96.9 105.92 USD |
-0.41
|
$4.33B 4.73B USD | $0 0 USD | $95.8 104.72 USD | $97.3 106.36 USD | $4.33B 4.73B USD | 48.93 | $1.98 2.16 USD | |
| Alpine Immune Sciences, Inc. 34LA.F | $59 64.49 USD |
0
|
$4.1B 4.48B USD | $20 21.86 USD | $59 64.49 USD | $59 64.49 USD | $4.1B 4.48B USD | 0 | -$0.59 -0.6 USD | |
| ALK-Abelló A/S 0OIR.IL | $149.45 21.91 USD |
0
|
$30B 4.4B USD | $11.24K 1.65K USD | $0 0 USD | $0 0 USD | $30B 4.4B USD | 92.82 | $1.61 0.24 USD | |
| Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
| Mirati Therapeutics MRTX | $58.7 — |
0
|
$4.12B — | $0 — | $0 — | $0 — | $4.12B — | 0 | $0 — | |
| Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | $7.1 7.76 USD |
-2.74
|
$3.75B 4.09B USD | $38 41.54 USD | $6.85 7.49 USD | $7.1 7.76 USD | $3.75B 4.09B USD | 10.28 | $0.69 0.75 USD | |
| Crinetics Pharmaceuticals, Inc. 6Z4.F | $46.4 50.72 USD |
-1.28
|
$3.66B 4B USD | $40 43.73 USD | $46.4 50.72 USD | $46.4 50.72 USD | $3.66B 4B USD | 0 | -$3.47 -3.7 USD | |
| BB Biotech AG BB.MI | $65.2 71.27 USD |
0
|
$3.58B 3.91B USD | $10.08K 11.02K USD | $51.6 56.41 USD | $52.9 57.83 USD | $3.58B 3.91B USD | 5.75 | $11.32 12.37 USD | |
| Insmed Incorporated IM8N.F | $23.4 25.58 USD |
+3.54
|
$3.48B 3.8B USD | $25 27.33 USD | $23.4 25.58 USD | $23.4 25.58 USD | $3.48B 3.8B USD | 0 | -$4.82 -5.2 USD | |
| CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
| Axsome Therapeutics, Inc. 19X.F | $71.22 77.85 USD |
+0.39
|
$3.42B 3.73B USD | $12 13.12 USD | $70.48 77.04 USD | $71.22 77.85 USD | $3.42B 3.73B USD | 0 | -$5.95 -6.5 USD | |
| CymaBay Therapeutics CBAY | $32.48 — |
0
|
$3.73B — | $0 — | $0 — | $0 — | $3.73B — | 0 | $0 — | |
| Insmed Incorporated IM8N.SG | $22.6 24.7 USD |
-0.88
|
$3.36B 3.67B USD | $0 0 USD | $22.6 24.7 USD | $23.4 25.58 USD | $3.36B 3.67B USD | 0 | -$4.82 -5.2 USD | |
| Ultragenyx Pharmaceutical Inc. UP0.F | $38 41.54 USD |
-1.04
|
$3.16B 3.45B USD | $100 109.31 USD | $38 41.54 USD | $38 41.54 USD | $3.16B 3.45B USD | 0 | -$7.32 -8.001 USD | |
| SK bioscience Co.,Ltd. 302440.KS | $58,200 43.93 USD |
+0.52
|
$4.47T 3.38B USD | $37.92K 28.63 USD | $57,600 43.48 USD | $58,300 44.01 USD | $4.47T 3.38B USD | 0 | $0 0 USD | |
| Syngene International Limited SYNGENE.BO | $693.55 8.39 USD |
-0.07
|
$278.32B 3.37B USD | $2.24K 27.1 USD | $692.15 8.37 USD | $698.4 8.45 USD | $278.32B 3.37B USD | 54.31 | $12.77 0.15 USD | |
| Galapagos NV GXE.DE | $44.47 48.61 USD |
0
|
$2.93B 3.2B USD | $1 1.09 USD | $44.18 48.29 USD | $44.47 48.61 USD | $2.93B 3.2B USD | 0 | -$1.92 -2.09 USD | |
| Genscript Biotech Corporation G51.F | $1.32 1.44 USD |
-5.71
|
$2.87B 3.14B USD | $900 983.82 USD | $1.32 1.44 USD | $1.32 1.44 USD | $2.87B 3.14B USD | 0 | -$0.04 -0.04 USD | |
| Arrowhead Pharmaceuticals, Inc. HDP1.F | $22.66 24.77 USD |
+0.22
|
$2.86B 3.13B USD | $20 21.86 USD | $22.66 24.77 USD | $22.66 24.77 USD | $2.86B 3.13B USD | 0 | -$3.9 -4.2 USD | |
| IDEAYA Biosciences, Inc. 30J.SG | $36.4 39.79 USD |
-1.62
|
$2.86B 3.12B USD | $0 0 USD | $36 39.35 USD | $36.4 39.79 USD | $2.86B 3.12B USD | 0 | -$1.84 -2.01 USD | |
| IDEAYA Biosciences, Inc. 30J.F | $36.4 39.79 USD |
-0.55
|
$2.86B 3.12B USD | $420 459.12 USD | $36.4 39.79 USD | $36.4 39.79 USD | $2.86B 3.12B USD | 0 | -$1.84 -2.01 USD | |
| VitaSpring Biomedical VSBC | $15 — |
0
|
$3.1B — | $242 — | $15 — | $15 — | $3.1B — | 0 | $0 — | |
| Xenon Pharmaceuticals Inc. XP0.F | $37.2 40.66 USD |
+1.64
|
$2.81B 3.07B USD | $20 21.86 USD | $37.2 40.66 USD | $37.2 40.66 USD | $2.81B 3.07B USD | 0 | -$2.5 -2.7 USD | |
| Corcept Therapeutics Incorporated HTD.F | $26.27 28.72 USD |
+2.86
|
$2.76B 3.02B USD | $50 54.66 USD | $26.25 28.69 USD | $26.5 28.97 USD | $2.76B 3.02B USD | 27.08 | $0.97 1.06 USD | |
| Iovance Biotherapeutics, Inc. 2LB.F | $9.85 10.77 USD |
+3.06
|
$2.76B 3.01B USD | $600 655.88 USD | $9.44 10.32 USD | $9.85 10.77 USD | $2.76B 3.01B USD | 0 | -$1.67 -1.8 USD | |
| Camurus AB (publ) 7CA.F | $47.52 51.95 USD |
-0.83
|
$2.76B 3.01B USD | $57 62.31 USD | $47.52 51.95 USD | $49.56 54.18 USD | $2.76B 3.01B USD | 70.92 | $0.67 0.73 USD | |
| Amicus Therapeutics, Inc. AM6.F | $8.9 9.73 USD |
+1.71
|
$2.75B 3.01B USD | $850 929.16 USD | $8.9 9.73 USD | $8.9 9.73 USD | $2.75B 3.01B USD | 0 | -$0.45 -0.4 USD | |
| Denali Therapeutics Inc. 4DN.MU | $18.62 20.35 USD |
-0.69
|
$2.66B 2.9B USD | $74 80.89 USD | $18.62 20.35 USD | $18.62 20.35 USD | $2.66B 2.9B USD | 0 | -$0.87 -0.9 USD | |
| Denali Therapeutics Inc. 4DN.F | $18.42 20.14 USD |
-0.86
|
$2.63B 2.87B USD | $100 109.31 USD | $18.42 20.14 USD | $18.42 20.14 USD | $2.63B 2.87B USD | 0 | -$0.87 -0.9 USD | |
| MorphoSys AG MOR.F | $68.05 74.39 USD |
-0.58
|
$2.58B 2.82B USD | $320 349.8 USD | $68.05 74.39 USD | $68.2 74.55 USD | $2.58B 2.82B USD | 0 | -$5.53 -6.04 USD | |
| MorphoSys AG MOR.VI | $68.3 74.66 USD |
-1.23
|
$2.58B 2.82B USD | $0 0 USD | $68.3 74.66 USD | $68.45 74.83 USD | $2.58B 2.82B USD | 0 | -$5.53 -6.04 USD | |
| MorphoSys AG MPSYF | $71.38 — |
-1.83
|
$2.79B — | $15.56K — | $71.38 — | $71.38 — | $2.79B — | 0 | -$6.01 — | |
| Maravai LifeSciences Holdings, Inc. MAR.F | $10 10.93 USD |
-0.99
|
$2.51B 2.75B USD | $500 546.57 USD | $9.85 10.77 USD | $10.3 11.26 USD | $2.51B 2.75B USD | 0 | -$0.91 -0.9 USD | |
| MorphoSys AG MOR2.F | $16.6 18.15 USD |
-2.35
|
$2.51B 2.74B USD | $100 109.31 USD | $16.6 18.15 USD | $16.6 18.15 USD | $2.51B 2.74B USD | 0 | -$1.38 -1.5 USD | |
| Immunocore Holdings plc 6YG.MU | $48 52.47 USD |
-0.41
|
$2.4B 2.62B USD | $13 14.21 USD | $48 52.47 USD | $48 52.47 USD | $2.4B 2.62B USD | 0 | -$1.32 -1.4 USD | |
| ACADIA Pharmaceuticals Inc. DR6.F | $13.8 15.09 USD |
+2.37
|
$2.38B 2.6B USD | $260 284.22 USD | $13.8 15.09 USD | $13.8 15.09 USD | $2.38B 2.6B USD | 0 | $0 0 USD | |
| Merus N.V. 2GH.F | $39.8 43.51 USD |
0
|
$2.36B 2.58B USD | $5 5.47 USD | $39.6 43.29 USD | $39.8 43.51 USD | $2.36B 2.58B USD | 0 | -$2.52 -2.7 USD | |
| TG Therapeutics, Inc. NKB2.F | $15.03 16.43 USD |
+0.01
|
$2.36B 2.58B USD | $215 235.02 USD | $15.03 16.43 USD | $15.03 16.43 USD | $2.36B 2.58B USD | 53.69 | $0.28 0.31 USD | |
| Immunocore Holdings plc 6YG.F | $47 51.38 USD |
-2.49
|
$2.35B 2.57B USD | $100 109.31 USD | $47 51.38 USD | $48.4 52.91 USD | $2.35B 2.57B USD | 0 | -$1.43 -1.5 USD | |
| Vericel Corporation ATQP.F | $46.6 50.94 USD |
+5.91
|
$2.31B 2.52B USD | $10 10.93 USD | $46.6 50.94 USD | $46.6 50.94 USD | $2.31B 2.52B USD | 4660.00 | $0.01 0.01 USD | |
| Celldex Therapeutics, Inc. TCE2.F | $34.2 37.39 USD |
-1.72
|
$2.29B 2.5B USD | $85 92.92 USD | $34.2 37.39 USD | $34.2 37.39 USD | $2.29B 2.5B USD | 0 | -$2.63 -2.8 USD | |
| Intellia Therapeutics, Inc. 38I.F | $23.41 25.59 USD |
-1.27
|
$2.28B 2.5B USD | $90 98.38 USD | $23.4 25.58 USD | $23.41 25.59 USD | $2.28B 2.5B USD | 0 | -$4.88 -5.3 USD | |
| BB Biotech AG Ord BBZA.F | $41.35 45.2 USD |
-2.25
|
$2.27B 2.48B USD | $3.55K 3.89K USD | $41.35 45.2 USD | $42 45.91 USD | $2.27B 2.48B USD | 0 | -$3.82 -4.1 USD | |
| Rhythm Pharmaceuticals, Inc. 1RV.F | $35.2 38.48 USD |
+2.92
|
$2.15B 2.35B USD | $50 54.66 USD | $35.2 38.48 USD | $35.4 38.7 USD | $2.15B 2.35B USD | 0 | -$4.26 -4.6 USD | |
| Geron Corporation GON.F | $3.39 3.7 USD |
-1.57
|
$2.02B 2.21B USD | $225 245.96 USD | $3.39 3.7 USD | $3.39 3.7 USD | $2.02B 2.21B USD | 0 | -$0.32 -0.3 USD | |
| BioArctic AB (publ) 0RV2.IL | $223.3 21.8 USD |
-6.29
|
$22.34B 2.18B USD | $460 44.9 USD | $0 0 USD | $0 0 USD | $22.34B 2.18B USD | 72.73 | $3.07 0.3 USD | |
| Bavarian Nordic A/S BV3.DE | $25.3 27.66 USD |
0
|
$1.99B 2.18B USD | $661 722.56 USD | $25 27.33 USD | $25.73 28.13 USD | $1.99B 2.18B USD | 45.17 | $0.56 0.61 USD | |
| Novavax, Inc. NVAX.MX | $248 14.68 USD |
+3.33
|
$36.53B 2.16B USD | $23.56K 1.4K USD | $234.41 13.88 USD | $256 15.16 USD | $36.53B 2.16B USD | 0 | -$50.49 -2.9 USD | |
| Rocket Pharmaceuticals, Inc. 9IP1.F | $20.84 22.78 USD |
+0.92
|
$1.89B 2.07B USD | $120 131.18 USD | $20.84 22.78 USD | $20.95 22.9 USD | $1.89B 2.07B USD | 0 | -$2.62 -2.8 USD | |
| Zai Lab Limited 1ZL.F | $18.1 19.79 USD |
-0.55
|
$1.85B 2.02B USD | $75 81.99 USD | $18.1 19.79 USD | $18.1 19.79 USD | $1.85B 2.02B USD | 0 | -$3.22 -3.5 USD | |
| Catalyst Pharmaceuticals, Inc. CN2.F | $15.31 16.74 USD |
+2.48
|
$1.84B 2.01B USD | $2K 2.19K USD | $15.31 16.74 USD | $15.31 16.74 USD | $1.84B 2.01B USD | 29.44 | $0.52 0.57 USD | |
| Galapagos NV G1LP34.SA | $7.29 1.48 USD |
-2.28
|
$9.87B 2B USD | $0 0 USD | $0 0 USD | $0 0 USD | $9.87B 2B USD | 2.79 | $2.61 0.53 USD | |
| Bavarian Nordic A/S BV3.F | $22.94 25.08 USD |
-2.63
|
$1.81B 1.98B USD | $200 218.63 USD | $22.94 25.08 USD | $23.9 26.13 USD | $1.81B 1.98B USD | 13.57 | $1.69 1.85 USD | |
| Bavarian Nordic A/S BVNRY | $8.36 — |
-2.52
|
$1.96B — | $8.37K — | $8.35 — | $8.48 — | $1.96B — | 13.70 | $0.61 — | |
| Bavarian Nordic A/S BVNKF | $22.69 — |
+7.03
|
$1.96B — | $103 — | $22.69 — | $22.69 — | $1.96B — | 12.33 | $1.84 — | |
| 3SBio Inc. 83B.F | $0.6899 0.75 USD |
-2.13
|
$1.79B 1.96B USD | $1K 1.09K USD | $0.65 0.71 USD | $0.6899 0.75 USD | $1.79B 1.96B USD | 8.62 | $0.08 0.09 USD | |
| Shanghai Haohai Biological Technology Co., Ltd. 5HB.F | $4.8 5.25 USD |
-1.23
|
$1.79B 1.96B USD | $300 327.94 USD | $4.8 5.25 USD | $4.8 5.25 USD | $1.79B 1.96B USD | 14.54 | $0.33 0.36 USD | |
| Galapagos NV GLPG.VI | $27.08 29.6 USD |
-1.17
|
$1.78B 1.95B USD | $0 0 USD | $27.08 29.6 USD | $27.08 29.6 USD | $1.78B 1.95B USD | 57.61 | $0.47 0.51 USD | |
| Galapagos NV GXEA.F | $26 28.42 USD |
0
|
$1.74B 1.9B USD | $150 163.97 USD | $26 28.42 USD | $26 28.42 USD | $1.74B 1.9B USD | 55.31 | $0.47 0.51 USD | |
| Galapagos NV GXE.F | $26 28.42 USD |
-4.62
|
$1.74B 1.9B USD | $300 327.94 USD | $26 28.42 USD | $27.02 29.54 USD | $1.74B 1.9B USD | 55.31 | $0.47 0.51 USD | |
| Agios Pharmaceuticals, Inc. 8AP.F | $30.4 33.23 USD |
-1.94
|
$1.74B 1.9B USD | $100 109.31 USD | $30.4 33.23 USD | $30.4 33.23 USD | $1.74B 1.9B USD | 0 | -$5.8 -6.3 USD | |
| BioArctic AB (publ) B9A.F | $20.2 22.08 USD |
+2.9
|
$1.7B 1.86B USD | $450 491.91 USD | $19.94 21.8 USD | $20.2 22.08 USD | $1.7B 1.86B USD | 91.81 | $0.22 0.24 USD | |
| Ardelyx, Inc. 41X.F | $7.13 7.79 USD |
+0.28
|
$1.67B 1.82B USD | $1.05K 1.15K USD | $7.13 7.79 USD | $7.17 7.84 USD | $1.67B 1.82B USD | 0 | -$0.26 -0.2 USD | |
| Neuren Pharmaceuticals NURPF | $13.56 — |
+6.91
|
$1.8B — | $1.76K — | $13.56 — | $13.56 — | $1.8B — | 16.94 | $0.8 — | |
| Ambrx Biopharma AMAM | $28 — |
0
|
$1.77B — | $0 — | $0 — | $0 — | $1.77B — | 0 | $0 — | |
| Syndax Pharmaceuticals, Inc. 1T3.F | $18.2 19.9 USD |
0
|
$1.62B 1.77B USD | $100 109.31 USD | $18.2 19.9 USD | $18.2 19.9 USD | $1.62B 1.77B USD | 0 | -$2.98 -3.2 USD | |
| Galapagos GLPGF | $26.2 — |
-27.62
|
$1.73B — | $190 — | $26.2 — | $26.2 — | $1.73B — | 51.37 | $0.51 — | |
| Veracyte, Inc. 12V.F | $20.4 22.3 USD |
-1.92
|
$1.56B 1.7B USD | $40 43.73 USD | $20.4 22.3 USD | $20.4 22.3 USD | $1.56B 1.7B USD | 0 | -$0.86 -0.9 USD | |
| Kura Oncology, Inc. KUR.F | $20.3 22.19 USD |
+0.5
|
$1.56B 1.7B USD | $50 54.66 USD | $20.3 22.19 USD | $20.3 22.19 USD | $1.56B 1.7B USD | 0 | -$2 -2.1 USD | |
| Agios Pharmaceuticals, Inc. AGIO.MX | $397.93 23.56 USD |
0
|
$28.11B 1.66B USD | $0 0 USD | $397.93 23.56 USD | $397.93 23.56 USD | $28.11B 1.66B USD | 0 | -$105.76 -6.2 USD | |
| Ligand Pharmaceuticals Incorporated LGDN.F | $80 87.45 USD |
+1.27
|
$1.46B 1.59B USD | $1 1.09 USD | $79.5 86.9 USD | $80 87.45 USD | $1.46B 1.59B USD | 16.26 | $4.92 5.38 USD | |
| Genus plc GBE.F | $21.4 23.39 USD |
+0.94
|
$1.45B 1.58B USD | $6 6.56 USD | $21.4 23.39 USD | $21.4 23.39 USD | $1.45B 1.58B USD | 36.27 | $0.59 0.64 USD | |
| Genus GENSF | $23 — |
-1.08
|
$1.58B — | $269 — | $23 — | $23 — | $1.58B — | 35.93 | $0.64 — | |
| PeptiDream PPTDF | $12.06 — |
+0.47
|
$1.56B — | $500 — | $12.06 — | $12.06 — | $1.56B — | 100.46 | $0.12 — | |
| Biotest Aktiengesellschaft BIO3.F | $27.5 30.06 USD |
+0.36
|
$1.38B 1.5B USD | $25 27.33 USD | $27.5 30.06 USD | $27.5 30.06 USD | $1.38B 1.5B USD | 8.59 | $3.2 3.5 USD | |
| Biotest Aktiengesellschaft BIO.F | $41 44.82 USD |
0
|
$1.37B 1.5B USD | $100 109.31 USD | $41 44.82 USD | $41 44.82 USD | $1.37B 1.5B USD | 12.81 | $3.2 3.5 USD | |
| Biotest Aktiengesellschaft BIO3.DE | $27.6 30.17 USD |
-0.36
|
$1.37B 1.5B USD | $689 753.17 USD | $27.5 30.06 USD | $27.8 30.39 USD | $1.37B 1.5B USD | 8.62 | $3.2 3.5 USD | |
| Biotest Aktiengesellschaft BIO.DE | $41.6 45.47 USD |
0
|
$1.37B 1.5B USD | $100 109.31 USD | $41.6 45.47 USD | $41.6 45.47 USD | $1.37B 1.5B USD | 12.99 | $3.2 3.5 USD | |
| Biotest Aktiengesellschaft BIO3.VI | $27.6 30.17 USD |
-0.36
|
$1.37B 1.49B USD | $0 0 USD | $27.6 30.17 USD | $27.7 30.28 USD | $1.37B 1.49B USD | 8.62 | $3.2 3.5 USD | |
| Morphic Holding, Inc. 31Y.F | $27.2 29.73 USD |
-0.73
|
$1.36B 1.49B USD | $139 151.95 USD | $27.2 29.73 USD | $27.2 29.73 USD | $1.36B 1.49B USD | 0 | -$3.32 -3.6 USD | |
| Xencor, Inc. XE9.F | $21.4 23.39 USD |
+2.88
|
$1.35B 1.48B USD | $300 327.94 USD | $21.4 23.39 USD | $21.4 23.39 USD | $1.35B 1.48B USD | 0 | -$2 -2.1 USD | |
|
Không có cổ phiếu ưa thích
Bạn chưa có cổ phiếu ưa thích nào, hãy thêm nó vào mục ưa thích để thấy nó tại đây |
||||||||||